#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Arrhythmogenic right ventricular dysplasia Myelofibrosis Angelman's syndrome Primary biliary cholangitis Primary myelofibrosis Mitochondrial encephalomyopathy Langerhans' cell histiocytosis Deafness neurosensory Undifferentiated sarcoma Cerebellar ataxia Myxoid liposarcoma Von Willebrand's disease Cholangiosarcoma Systemic mastocytosis Haemophilia More trials…

    Learn about Rare Diseases

    Familial amyotrophic lateral sclerosis Myelodysplastic syndrome – Life with Disease Pemphigus – Treatment Medulloblastoma recurrent – Treatment Cystic fibrosis lung Tuberous sclerosis complex – Life with Disease Haemophilia B with anti factor IX Wiskott-Aldrich syndrome – Treatment Hairy cell leukaemia – Diagnostics Alagille syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    (-)-PHENSERINE TARTRATE Rifampicin GAXILOSE GSKVX000000044501 Regn7075 Meclofenamate Sodium Trehalose Dihydrate (Ph.eur.) Afamelanotide Ethinylestradiol Ucp4 Oleclumab Itraconazole Mitazalimab Ucp2 Temocillin Sodium Navitoclax Ursodoxicoltaurine UDONITRECTAG Nortriptyline Hydrochloride AZD3632 More therapies…

    Learn about Your Condition

    Foetal growth restriction Fabry's disease Glomerulonephritis chronic Duchenne muscular dystrophy Cushing's syndrome Asthmatic crisis Laryngeal leukoplakia Aplasia pure red cell Type 1 diabetes mellitus Pneumothorax Rubella Alveolar rhabdomyosarcoma Procedural hypotension Carotid arteriosclerosis Gastrectomy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Schwerpunktpraxis für Diabetes Hormone & Stoffwechsel…

Schwerpunktpraxis für Diabetes Hormone & Stoffwechsel

August-Mohl-Strasse 37, Hof, N/A, Germany, Hof, 95030, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Comparison of weekly insulin icodec versus daily basal insulin in adults with type 2 diabetes who have not used insulin before

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • INSULIN DEGLUDEC
    • INSULIN DETEMIR
    • Insulin Glargine
    Germany Italy
  • Evaluating Once Daily Orforglipron (LY3502970) Compared to Insulin Glargine in Adults with Type 2 Diabetes and Obesity or Overweight who Have Increased Cardiovascular Risk

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Canagliflozin
    • Ertugliflozin
    • Insulin Glargine
    Austria Czechia Germany Greece Italy Romania +2

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!